Literature DB >> 18362827

Comparison of resource utilization for Medicaid dementia patients using nursing homes versus home and community based waivers for long-term care.

Laura P Sands1, Huiping Xu, Michael Weiner, Marc B Rosenman, Bruce A Craig, Joseph Thomas.   

Abstract

BACKGROUND: Medicaid waiver home and community-based long-term care services (HCBS) may provide a partial solution to the escalating costs of long-term care. Persons with dementia can have complex caregiving needs; it is unknown whether their expenditures and resource utilization differ between community-based versus institutional settings.
OBJECTIVE: To compare expenditures and resource utilization for Medicaid recipients with dementia who received long-term care through a nursing home versus HCBS waivers.
DESIGN: Twelve-month cohort study.
SETTING: Indiana Medicaid administrative data from 2001 through 2004. PARTICIPANTS: Medicaid recipients with dementia who lived in the community 6 months before receiving long-term care through nursing homes (N = 1534) or HCBS waivers (N = 174). MEASUREMENTS: Monthly inpatient and emergency department rates and total expenditures adjusted for prior use, demographics, insurance status, and comorbidities.
RESULTS: Adjusted rates of inpatient use were stable for nursing home patients (0.06) but significantly increased over 12 months for HCBS recipients (0.07-0.12; P = 0.048). Adjusted total expenditures increased over 12 months from $1419 to $2002 for HCBS recipients (P < 0.001), but remained stable for those in nursing homes ($3413-$3336). Long-term care expenditures were on average $1688 per month higher for those in nursing homes.
CONCLUSIONS: The escalation in inpatient use for HCBS waiver recipients suggests that future development of HCBS programs should consider the unique needs of persons with dementia so as to optimize their health outcomes. Despite increasing inpatient use among HCBS recipients, their overall expenditures remained significantly lower than those of nursing home patients.

Entities:  

Mesh:

Year:  2008        PMID: 18362827     DOI: 10.1097/MLR.0b013e3181621eae

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  7 in total

1.  Quality of Care for Chronic Conditions Among Disabled Medicaid Enrollees: An Evaluation of a 1915 (b) and (c) Waiver Program.

Authors:  Martin P Wegman; Jill B Herndon; Keith E Muller; Garth N Graham; W Bruce Vogel; Kimberly H Case; Jason A Lee; Matthew F Van Voorhis; Elizabeth A Shenkman
Journal:  Med Care       Date:  2015-07       Impact factor: 2.983

2.  Volume of home- and community-based services and time to nursing-home placement.

Authors:  Laura P Sands; Huiping Xu; Joseph Thomas; Sudeshna Paul; Bruce A Craig; Marc Rosenman; Caroline C Doebbeling; Michael Weiner
Journal:  Medicare Medicaid Res Rev       Date:  2012-08-06

3.  HCBS Service Spending and Nursing Home Placement for Patients With Alzheimer's Disease and Related Dementias: Does Race Matter?

Authors:  Di Yan; Sijiu Wang; Helena Temkin-Greener; Shubing Cai
Journal:  J Appl Gerontol       Date:  2021-10-07

4.  Opportunity costs associated with caring for older Mexican-Americans.

Authors:  H Shelton Brown; Angelica P Herrera; Jacqueline L Angel
Journal:  J Cross Cult Gerontol       Date:  2013-09

5.  Health Care Service Utilization of Dementia Patients before and after Institutionalization: A Claims Data Analysis.

Authors:  Larissa Schwarzkopf; Yi Hao; Rolf Holle; Elmar Graessel
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2014-06-28

6.  Potentially Avoidable Hospitalization among Long-Term Care Insurance Beneficiaries with Dementia.

Authors:  Jae-Hyun Kim; Yunhwan Lee
Journal:  Korean J Fam Med       Date:  2020-04-22

7.  Are community-living and institutionalized dementia patients cared for differently? Evidence on service utilization and costs of care from German insurance claims data.

Authors:  Larissa Schwarzkopf; Petra Menn; Reiner Leidl; Elmar Graessel; Rolf Holle
Journal:  BMC Health Serv Res       Date:  2013-01-03       Impact factor: 2.655

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.